19.06.2020 14:28:21
|
Perrigo To Divest U.K-based Generic Prescription Pharmaceuticals Business - Quick Facts
(RTTNews) - Perrigo Co. plc (PRGO) announced Friday that it has reached a definitive agreement to sell its U.K.-based non-core generic prescription pharmaceuticals business to a U.K.-headquartered private equity firm for 156 million British pounds or about $195 million in cash.
This transaction, which was signed and closed on the same day, represents another step in Perrigo's transformation to a consumer-focused self-care company.
Perrigo's U.K.-based Rosemont Pharmaceuticals is a generic prescription pharmaceuticals manufacturer focused on liquid medicines.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Perrigo Company PLCmehr Nachrichten
Analysen zu Perrigo Company PLCmehr Analysen
Aktien in diesem Artikel
Perrigo Company PLC | 23,99 | -0,29% |
|